Skip to the page

Data / Form D filings / BioConsortia, Inc.

BioConsortia, Inc.: Form D filings

BioConsortia, Inc., a company in Davis, CA, filed 5 Form D notices with the SEC between 2016 and 2023. The latest, on April 20, 2023, reports $15 million sold of a $15 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
279 CONSTEAU PLACE, SUITE 100, Davis, CA, 95618
Phone
(530) 564-5572
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1688416

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 20, 2023New notice$15,000,000$15,000,0001Apr 17, 2023sec.gov
Mar 27, 2019Amendment$8,000,000$8,000,0003Mar 26, 2019sec.gov
Mar 27, 2019New notice$8,000,000$0$8,000,0003Mar 26, 2019sec.gov
Mar 13, 2018New notice$10,000,010$10,000,0103Mar 2, 2018sec.gov
Oct 27, 2016New notice$7,999,999$7,999,9995Oct 25, 2016sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Marcus Meadows-SmithExecutive Officer, Director
Christina HubenExecutive Officer
John M. PasquesiDirector

Other companies in California that filed recently

Every Form D from the week of Apr 17, 2023 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what BioConsortia, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.